Krystle N. Agans

4.3k total citations
80 papers, 2.7k citations indexed

About

Krystle N. Agans is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Krystle N. Agans has authored 80 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Infectious Diseases, 41 papers in Epidemiology and 8 papers in Modeling and Simulation. Recurrent topics in Krystle N. Agans's work include Viral Infections and Outbreaks Research (57 papers), Viral Infections and Vectors (50 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Krystle N. Agans is often cited by papers focused on Viral Infections and Outbreaks Research (57 papers), Viral Infections and Vectors (50 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Krystle N. Agans collaborates with scholars based in United States, France and Canada. Krystle N. Agans's co-authors include Thomas W. Geisbert, Karla A. Fenton, Joan B. Geisbert, Chad E. Mire, Robert W. Cross, Daniel J. Deer, Viktoriya Borisevich, Courtney Woolsey, Abhishek N. Prasad and Benjamin A. Satterfield and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Krystle N. Agans

78 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Krystle N. Agans United States	32	2.1k	1.3k	488	246	218	80	2.7k
Karla A. Fenton United States	31	2.1k 1.0×	1.2k 0.9×	355 0.7×	337 1.4×	198 0.9×	72	2.6k
Robert W. Cross United States	29	2.0k 0.9×	1.1k 0.8×	300 0.6×	247 1.0×	211 1.0×	89	2.4k
Valentina A. Volchkova France	30	2.7k 1.3×	1.4k 1.0×	364 0.7×	207 0.8×	279 1.3×	42	3.2k
Larissa Kolesnikova Germany	37	2.5k 1.2×	1.2k 0.9×	663 1.4×	200 0.8×	230 1.1×	63	3.4k
Joshua C. Johnson United States	23	1.7k 0.8×	606 0.5×	353 0.7×	126 0.5×	326 1.5×	46	2.1k
Thomas Hoenen Germany	30	2.4k 1.1×	826 0.6×	440 0.9×	204 0.8×	267 1.2×	95	2.9k
Olga Dolnik Germany	29	2.2k 1.0×	767 0.6×	405 0.8×	143 0.6×	198 0.9×	57	2.9k
Allison Groseth Germany	27	2.3k 1.1×	719 0.5×	272 0.6×	297 1.2×	284 1.3×	72	2.5k
Alan Schmaljohn United States	29	2.8k 1.3×	1.2k 0.9×	577 1.2×	428 1.7×	329 1.5×	38	3.6k
Anthony Sanchez United States	26	3.3k 1.5×	1.4k 1.0×	384 0.8×	281 1.1×	627 2.9×	31	3.9k

Countries citing papers authored by Krystle N. Agans

Since Specialization

Citations

This map shows the geographic impact of Krystle N. Agans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krystle N. Agans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krystle N. Agans more than expected).

Fields of papers citing papers by Krystle N. Agans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krystle N. Agans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krystle N. Agans. The network helps show where Krystle N. Agans may publish in the future.

Co-authorship network of co-authors of Krystle N. Agans

This figure shows the co-authorship network connecting the top 25 collaborators of Krystle N. Agans. A scholar is included among the top collaborators of Krystle N. Agans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krystle N. Agans. Krystle N. Agans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cross, Robert W., Jacquelyn Turcinovic, Abhishek N. Prasad, et al.. (2026). Oral 4′-fluorouridine rescues nonhuman primates from advanced Lassa fever. Nature. 650(8103). 961–969.

Cross, Robert W., Courtney Woolsey, Abhishek N. Prasad, et al.. (2025). Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates. Nature Medicine. 31(4). 1303–1311. 5 indexed citations

Prasad, Abhishek N., Courtney Woolsey, Viktoriya Borisevich, et al.. (2025). Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virus. Nature Communications. 16(1). 3824–3824. 1 indexed citations

Leyva-Grado, Victor H., Dominique Promeneur, Krystle N. Agans, et al.. (2024). Establishing an immune correlate of protection for Nipah virus in nonhuman primates. npj Vaccines. 9(1). 244–244.

Cross, Robert W., Abhishek N. Prasad, Courtney Woolsey, et al.. (2023). Natural history of nonhuman primates after conjunctival exposure to Ebola virus. Scientific Reports. 13(1). 4175–4175. 10 indexed citations

Wong, Teri Ann S., Michael M. Lieberman, Jake Yalley-Ogunro, et al.. (2023). Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine. 42(3). 598–607. 4 indexed citations

Cross, Robert W., Megan L. Heinrich, Karla A. Fenton, et al.. (2023). A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proceedings of the National Academy of Sciences. 120(34). e2304876120–e2304876120. 17 indexed citations

Hunegnaw, Ruth, Anna N. Honko, Lingshu Wang, et al.. (2022). A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates. Science Translational Medicine. 14(675). eabq6364–eabq6364. 25 indexed citations

Cross, Robert W., Courtney Woolsey, Abhishek N. Prasad, et al.. (2022). A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever. Cell Reports. 40(3). 111094–111094. 27 indexed citations

10.

Foster, Stephanie L., Courtney Woolsey, Viktoriya Borisevich, et al.. (2022). A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proceedings of the National Academy of Sciences. 119(12). e2200065119–e2200065119. 38 indexed citations

11.

Fontes, Cassio M., Jason Liu, Krystle N. Agans, et al.. (2021). Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR. Science Translational Medicine. 13(588). 24 indexed citations

12.

Zeitlin, Larry, Robert W. Cross, Joan B. Geisbert, et al.. (2021). Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proceedings of the National Academy of Sciences. 118(11). 14 indexed citations

13.

Mire, Chad E., Yee‐Peng Chan, Viktoriya Borisevich, et al.. (2019). A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. The Journal of Infectious Diseases. 221(Supplement_4). S471–S479. 49 indexed citations

14.

Russo, Andrew T., Douglas W. Grosenbach, Trevor Brasel, et al.. (2018). Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques. The Journal of Infectious Diseases. 218(9). 1490–1499. 61 indexed citations

15.

Matassov, Demetrius, Chad E. Mire, Theresa Latham, et al.. (2017). Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge. Journal of Virology. 92(3). 35 indexed citations

16.

Mire, Chad E., Joan B. Geisbert, Viktoriya Borisevich, et al.. (2017). Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Science Translational Medicine. 9(384). 69 indexed citations

17.

Satterfield, Benjamin A., Robert W. Cross, Karla A. Fenton, et al.. (2016). Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets. Journal of Virology. 90(14). 6326–6343. 40 indexed citations

18.

Thi, Emily P., Chad E. Mire, Amy C. H. Lee, et al.. (2015). Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature. 521(7552). 362–365. 190 indexed citations

19.

Mire, Chad E., Robert W. Cross, Krystle N. Agans, et al.. (2013). Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virology Journal. 10(1). 353–353. 64 indexed citations

20.

Mire, Chad E., Joan B. Geisbert, Andrea Marzi, et al.. (2013). Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus. PLoS neglected tropical diseases. 7(12). e2600–e2600. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact